Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin lymphoma

Mélody Caillot (1) , Hadjer Miloudi (1) , Antoine Taly (2) , Nuria Profitós-Pelejà (3) , Juliana Santos (3) , Marcelo Ribeiro (3) , Elsa Maitre (1, 4) , Simon Saule (5) , Gaël Roué (3) , Fabrice Jardin (1) , Brigitte Sola (1)

1 GPMCND - Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques
2 LBT (UPR_9080) - Laboratoire de biochimie théorique [Paris]
3 IJC - Josep Carreras Leukaemia Research Institute
4 Laboratoire d'Hématologie Biologique [CHU Caen]
5 Institut Curie, Research Center, PSL Research University,

Domains: Life Sciences [q-bio]

Mélody Caillot, Hadjer Miloudi, Antoine Taly, Nuria Profitós-Pelejà, Juliana Santos, et al.. Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin lymphoma. Molecular Oncology, 2023, ⟨10.1002/1878-0261.13386⟩. ⟨hal-03974823⟩